News
Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib
No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants
Your search for Warfarin returned 191 results
News
Time of Day for Taking Warfarin Does Not Matter
Morning or evening administration makes no difference on time outside target INR range.
News
Low-Intensity Warfarin Not Noninferior in Hip, Knee Surgery
Noninferiority not found compared with standard-intensity prophylaxis with hip or knee arthroplasty
News
“Liver Cleanse” Linked to INR Increase in Warfarin-Treated Patient
The patient in this case had been well-controlled on warfarin therapy for over 5 years following mitral valve replacement.
News
Rivaroxaban Compared With Warfarin in Morbidly Obese Patients With VTE
Results from a new real-world study evaluating rivaroxaban (Xarelto; Janssen), a factor Xa inhibitor, in morbidly obese patients were recently published in Thrombosis Research. The retrospective cohort study analyzed data from 2 US claims databases (Truven MarketScan Commercial Claims and Encounters database and MarketScan Medicare Supplemental database) to evaluate the clinical and health/economic outcomes of…
News
Cannabis Use Leads to INR Elevation in Warfarin-Treated Patient
“The elevation in INR can be explained by the inhibition of CYP2C9 by cannabis use causing decreased metabolism of warfarin,” the authors explained.
News
Vitamin K Can Up Anticoagulation Stability in Patients on Warfarin
Findings seen in warfarin-treated patients with history of international normalized ratio instability
News
Reversal of Warfarin-Associated Bleeding With 4F-PCC Examined in Obese Patients
To investigate an appropriate dosing strategy for 4F-PCC (Kcentra; CSL Behring) in obese patients, the authors conducted a retrospective analysis comparing the reversal of warfarin using adjusted (N=28) vs actual body weight (N=50).
News
Safety of Direct Oral Anticoagulants Versus Warfarin Investigated
Compared with warfarin, apixaban was correlated with reduced risk of major bleeding and intracranial bleeding (adjusted hazard ratios, 0.66 and 0.4, respectively) and dabigatran was correlated with reduced risk of intracranial bleeding (adjusted hazard ratio, 0.45) among patients with atrial fibrillation.
News
Extended INR Test Intervals Safe for Warfarin-Treated Patients
Similar number of out-of-range next INR values for patients with, without extended testing interval
